Researchers receive £2.66M to test new immunotherapeutic strategy for non-small cell lung cancer

University of Liverpool researchers have secured £2.66m Medical Research Council funding to clinically test a novel immunotherapeutic strategy for non-small cell lung cancer – one of the most deadly cancers.

Biotech Bonanza 2023 Biotech OutlookAs The FED Remains Hawkish • Prudent Biotech

Federal Reserve interest rate policy to again remain the market focus this year and create a chaotic first half. Biotechs should be favorably positioned relative

January 10, 2023

Califf lays out drug shortage landscape, talks post-market data collection for accelerated approvals

Efforts to inspect generic drug facilities around the world could end up worsening US shortages of several key medicines if they lead to halted manufacturing,

February 29, 2024

4D XStrain STE: A reliable, economical tool for estimating regional and global myocardial function

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Because of its excellent ability to non-invasively assess left ventricular (LV) systolic function, two-dimensional

March 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.